Certificate of Analysis
CJC-1295 + Ipamorelin — lot 251212CL103
Values below are transcribed from the signed certificate for this lot, issued by an ISO/IEC 17025 accredited laboratory and tested Jan 6, 2026. They describe the material’s identity and purity only.
99.04%
Purity by HPLC
| Compound identity | CJC-1295 (no DAC) / Ipamorelin |
|---|---|
| Variant | CJC-1295 / Ipamorelin · 10 mg / 10 mg |
| Lot number | 251212CL103 |
| Labeled amount | 10 mg / 10 mg |
| Assayed net peptide | 11.05 mg (CJC-1295) |
| Purity (HPLC) | 99.04% |
| Date tested | Jan 6, 2026 |
| Sterility (USP <71>) | No growth detected |
| Bacterial endotoxin (LAL) | < 0.05 EU/mg |
| Heavy metals (ICP-MS) | Screened — Cr, As, Cd, Pb, Hg |
| Issuing laboratory | Vanguard Laboratory |
| Accreditation | ISO/IEC 17025 (A2LA cert #6377.01.01) |
Research use only. Not for human consumption or veterinary use. Sold exclusively to qualified researchers for in vitro and laboratory research. These statements have not been evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease. Refrigerate upon receipt. Keep in dark environment.